Back to Search
MARYAM TABRIZI, M.D
M.D
Family Medicine Physician
NPI: 1932402476IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
A118850(CA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 1992
Research & Publications (20)
Translational strategies for development of monoclonal antibodies from discovery to the clinic.
PMID 19152840·Drug Discov Today·2009
6-review
Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial.
PMID 17207172·J Eur Acad Dermatol Venereol·2007
2-rct
Preclinical and clinical safety of monoclonal antibodies.
PMID 17631248·Drug Discov Today·2007
6-review
Elimination mechanisms of therapeutic monoclonal antibodies.
PMID 16478695·Drug Discov Today·2006
6-review
Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.
PMID 19626278·Invest New Drugs·2010
7-preclinical
Autocrine human growth hormone expression leads to resistance of MCF-7 cells to tamoxifen.
PMID 19472088·Med Oncol·2010
4-observational
How accurate are self-reports? Analysis of self-reported health care utilization and absence when compared with administrative data.
PMID 19528832·J Occup Environ Med·2009
4-observational
Health improvement from a worksite health promotion private-public partnership.
PMID 19225415·J Occup Environ Med·2009
8-other
Recent developments in A2B adenosine receptor ligands.
PMID 19639280·Handb Exp Pharmacol·2009
6-review
Recent improvements in the development of A(2B) adenosine receptor agonists.
PMID 19184536·Purinergic Signal·2009
8-other
Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
PMID 18297692·Synapse·2008
7-preclinical
Recent improvements in the development of A(2B) adenosine receptor agonists.
PMID 18443746·Purinergic Signal·2008
8-other
Using a return-on-investment estimation model to evaluate outcomes from an obesity management worksite health promotion program.
PMID 18784545·J Occup Environ Med·2008
8-other
Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
PMID 18260616·J Med Chem·2008
7-preclinical
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists.
PMID 19006671·Bioorg Med Chem·2008
7-preclinical
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
PMID 18077171·Bioorg Med Chem·2008
8-other
Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility.
PMID 18181659·Chem Rev·2008
6-review
Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission.
PMID 18231915·Leuk Lymphoma·2008
8-other
Application of analytical detection concepts to immunogenicity testing.
PMID 17922557·Anal Chem·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 699 W TEFFT ST STE A
NIPOMO, CA 93444 - Phone
- (805) 930-9995
Quick Facts
- NPI
- 1932402476
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile